2007
DOI: 10.1157/13099467
|View full text |Cite
|
Sign up to set email alerts
|

Carbo-stent liberador de tacrolimus Janus®. Resultados inmediatos y seguimiento clínico a medio plazo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2009
2009
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 11 publications
0
1
0
Order By: Relevance
“…The Firehawk stent is claimed to have the world’s lowest drug dosage, with only a fraction of the drug loadings of other drug-eluting stents. The Janus stent is unique in that, once the drug tacrolimus is loaded into the reservoirs, the stent is then coated with a surface layer that prevents stent thrombosis and enhances biocompatibility [ 18 ].…”
Section: Introductionmentioning
confidence: 99%
“…The Firehawk stent is claimed to have the world’s lowest drug dosage, with only a fraction of the drug loadings of other drug-eluting stents. The Janus stent is unique in that, once the drug tacrolimus is loaded into the reservoirs, the stent is then coated with a surface layer that prevents stent thrombosis and enhances biocompatibility [ 18 ].…”
Section: Introductionmentioning
confidence: 99%